Study guide

25.1 Classification of Contrast Agents: Osmolality, Viscosity & Iodine Concentration

Philippine Radiologic Technologists Licensure Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Subject 1, Chapter 1: Physics of Radiology & X-Ray Production

1.1 Atomic Structure, Electromagnetic Spectrum & X-Ray Production Mechanisms 1.2 X-Ray Tube Components, Target Interactions & Emission Spectrum 1.3 Photon Interactions with Matter: Photoelectric, Compton, Coherent & Pair Production

2 Subject 1, Chapter 2: Radiographic Equipment & Circuitry

2.1 High-Voltage Generators, Transformers & Rectification Circuits 2.2 Automatic Exposure Control (AEC), Beam Restriction & Quality Control 2.3 Tube Rating Charts, Extending Tube Life, Mechanical Malfunction & Preventive Maintenance

3 Subject 1, Chapter 3: Radiobiology & Cellular Response

3.1 Radiation Interaction with Tissue, Direct/Indirect Action & LET/RBE 3.2 Law of Bergonie & Tribondeau, Deterministic vs. Stochastic Effects 3.3 Dose-Response Relationships, Embryo and Fetal Effects & Acute Radiation Syndrome

4 Subject 1, Chapter 4: Radiation Protection & Dose Limits

4.1 ALARA Principles, Structural Shielding & Dose Limits 4.2 Personnel Dosimetry & Patient Dose Reduction Techniques 4.3 Dose Calculation Problems: Time, Distance, Shielding & Structural Barrier Design

5 Subject 1, Chapter 5: Imaging Informatics & Quality Assurance

5.1 PACS Architecture, DICOM Standards & HL7 Integration 5.2 Quality Assurance & Quality Control Protocols in Diagnostic Radiography 5.3 Radiology Workflow, RIS/HIS Integration, Teleradiology & Informatics Quality Assurance

6 Subject 2, Chapter 6: Film-Screen Radiography & Sensitometry

6.1 Film Emulsion, Latent Image Formation & Darkroom Chemistry 6.2 Sensitometric Curve (H&D Curve), Film Speed & Contrast Characteristics 6.3 Radiographic Film Analysis: Processing Faults, Handling Artifacts & Corrective Measures

7 Subject 2, Chapter 7: Technical Factors & Radiographic Quality

7.1 Density/Brightness, Contrast, Spatial Resolution & Distortion Controls 7.2 Exposure Math: Inverse Square Law, 15% Rule & Grid Conversion Factors 7.3 Technique Compensation: Age, Pathology, Cast and Orthopaedic Devices, Screen Speed & Beam Restriction

8 Subject 2, Chapter 8: Computed Radiography (CR)

8.1 Photostimulable Phosphor (PSP) Plates & CR Reader Mechanics 8.2 Image Processing, CR Artifacts & Erasure Protocols

9 Subject 2, Chapter 9: Digital Radiography (DR)

9.1 Flat-Panel Detectors: Direct vs. Indirect Conversion & TFT Arrays 9.2 Detective Quantum Efficiency (DQE), Modulation Transfer Function (MTF) & Dynamic Range

10 Subject 2, Chapter 10: Exposure Indicators & Image Evaluation

10.1 Exposure Indicators (S-Number, EI, DI), Windowing & Look-Up Tables (LUT) 10.2 Image Critique Checklist, Artifact Identification & Quality Control Standards 10.3 Image Display & Hard-Copy Output: Monitor Classification, DICOM GSDF, Dry vs Wet Laser Imaging

11 Subject 3, Chapter 11: Chest, Abdomen & Routine Positioning Concepts

11.1 Anatomical Terminology, Body Planes & Chest Radiography (PA, Lateral, Decubitus) 11.2 Abdominal Radiography: Acute Abdomen Series & Erect/Supine Protocols 11.3 Radiologic Surface Anatomy, Body Habitus & Sectional Body Cuts

12 Subject 3, Chapter 12: Upper & Lower Extremities & Girdles

12.1 Upper Limb & Shoulder Girdle Positioning (Hand, Wrist, Forearm, Elbow, Humerus, Shoulder) 12.2 Lower Limb & Pelvic Girdle Positioning (Foot, Ankle, Leg, Knee, Femur, Pelvis, Hip)

13 Subject 3, Chapter 13: Spine & Bony Thorax

13.1 Cervical, Thoracic & Lumbar Spine Radiography & Trauma Adaptations 13.2 Sacrum, Coccyx, Sacroiliac Joints & Bony Thorax (Ribs & Sternum)

14 Subject 3, Chapter 14: Cranium, Facial Bones & Paranasal Sinuses

14.1 Skull Positioning: Towne, Caldwell, Lateral & SMV Projections 14.2 Facial Bones, Orbits, Zygomatic Arches & Paranasal Sinuses

15 Subject 3, Chapter 15: Contrast Media Studies & Special Procedures

15.1 Gastrointestinal Contrast Procedures (Esophagram, UGI, Small Bowel, Barium Enema) 15.2 Genitourinary, Biliary & Special Fluoroscopic Studies (IVU, Cystography, ERCP, Myelography) 15.3 Reproductive System Studies: Hysterosalpingography, Pelvimetry & Male Reproductive Procedures 15.4 Nasopharyngography, Sialography & Fistulography / Sinus Tract Visualization

16 Subject 4, Chapter 16: Human Anatomy, Physiology & Pathology Integration

16.1 Body System Anatomy & Systemic Physiology Overview for Radiographers 16.2 Radiologic Pathology: Image Manifestations of Neoplastic, Inflammatory & Traumatic Conditions

17 Subject 4, Chapter 17: Patient Assessment, Communication & Informed Consent

17.1 Professional Communication, History Taking & Patient Rights 17.2 Informed Consent, Medical Documentation & Patient Transfer Safety

18 Subject 4, Chapter 18: Infection Control & Vital Signs Monitoring

18.1 Standard Precautions, Asepsis, Sterilization & Isolation Protocols 18.2 Measurement & Assessment of Vital Signs (BP, Pulse, Respiration, Temperature)

19 Subject 4, Chapter 19: Emergency Care & Aseptic Venipuncture

19.1 Basic Life Support (BLS), CPR Concepts & Emergency Response in Radiology 19.2 Aseptic Venipuncture Technique, IV Maintenance & Extravasation Care

20 Subject 4, Chapter 20: Professional Ethics, Jurisprudence & RA 7431

20.1 Republic Act No. 7431 (Radiologic Technology Act of 1992) & Board Rules 20.2 Code of Professional Ethics, Legal Liabilities, Malpractice & Negligence 20.3 Bioethical Principles in Practice, Professional Virtues & Interprofessional Relationships

21 Subject 5, Chapter 21: Diagnostic Ultrasonography

21.1 Ultrasound Physics, Transducer Construction & Doppler Principles 21.2 Acoustic Artifacts, Clinical Applications & Safety (TI/MI) 21.3 Clinical Ultrasound Examinations: Indications, Patient Preparation, Scanning Protocols & Transducer Selection

22 Subject 5, Chapter 22: Computed Tomography (CT)

22.1 CT Physics, Gantry Components, Detectors & Helical/Multislice Acquisition 22.2 Hounsfield Units, Windowing, CT Artifacts & Radiation Dose (CTDI/DLP)

23 Subject 5, Chapter 23: Magnetic Resonance Imaging (MRI)

23.1 MRI Physics, Nuclear Spin, T1/T2 Relaxation & Pulse Sequences 23.2 MRI Safety (Zones I-IV, SAR, Metallic Implants) & Common Artifacts 23.3 MRI Examination Protocols, Patient Preparation, Gadolinium Contrast & Sectional MRI Anatomy

24 Subject 5, Chapter 24: Interventional Radiology & Vascular Imaging

24.1 Vascular Access, Seldinger Technique & Digital Subtraction Angiography (DSA) 24.2 Interventional Procedures (Embolization, Angioplasty, Stenting) & C-Arm Radiation Safety 24.3 Interventional Patient Management: Contrast Selection, Pre-Procedure Workup & Post-Procedure Care

25 Subject 5, Chapter 25: Contrast Media Pharmacology & Adverse Reactions

25.1 Classification of Contrast Agents: Osmolality, Viscosity & Iodine Concentration 25.2 Adverse Contrast Reactions (Mild, Moderate, Severe) & Emergency Treatment Protocols 25.3 General Pharmacologic Principles: Pharmacokinetics, Pharmacodynamics, Drug Categories & the Rights of Drug Safety

26 Subject 5, Chapter 26: Nuclear Medicine & Molecular Imaging

26.1 Radioisotopes, Radiopharmaceuticals & Gamma Camera / SPECT Operation 26.2 Positron Emission Tomography (PET/CT) & Unsealed Radiation Source Safety

27 Subject 5, Chapter 27: Radiation Therapy & Radiation Oncology

27.1 Principles of Radiation Oncology, Linear Accelerators & Treatment Planning 27.2 Teletherapy vs. Brachytherapy, Patient Immobilization & Side Effect Management 27.3 Isodose Planning, Treatment Delivery Methods & Radiobiologic Principles in Radiation Therapy

28 Mammography & Dental Radiography

28.1 Mammography: Equipment, CC and MLO Positioning, Compression & Breast Pathology 28.2 Dental Radiography: Paralleling and Bisecting Techniques, Bitewing, Occlusal, Panoramic & Cephalometric

29 Medical Terminology for Radiologic Technology

29.1 Medical Word Building: Root Words, Combining Forms, Prefixes & Suffixes 29.2 Medical Terms in General Medicine, Abbreviations, Symbols & Critiquing Requests and Reports

30 Radiology Administration, Organization & Leadership

30.1 Organizational Structure, Staffing & Licensing Requirements of a Radiology Facility 30.2 Radiology Department Management: Job Descriptions, Duties, Leadership Styles & Entrepreneurial Skills

25.1 Classification of Contrast Agents: Osmolality, Viscosity & Iodine Concentration

Key Takeaways Explain This Topic AI

Positive contrast agents possess high atomic numbers (Z=53 for Iodine, Z=56 for Barium) and increase photoelectric absorption to appear bright white, while negative agents (air, CO2) have low atomic numbers and appear dark.

High-Osmolar Contrast Media (HOCM) ionic monomers dissociate into 2 ions per 3 iodine atoms (1.5 ratio), creating extreme hyperosmolality (1500–2000 mOsm/kg H2O) and significantly higher toxicity compared to blood plasma (~290 mOsm/kg H2O).

Non-ionic Low-Osmolar Contrast Media (LOCM) like Iohexol and Iopamidol do not dissociate in solution (3.0 ratio), yielding osmolality levels of 600–800 mOsm/kg H2O, which dramatically reduces heat, pain, and systemic adverse reactions.

Warming contrast media to body temperature (37°C) in a dedicated warming sleeve reduces fluid viscosity by approximately 50%, facilitating high-flow injections through fine catheters and lowering injection pressures.

Contrast-Induced Nephropathy (CIN) is defined as a ≥0.5 mg/dL or ≥25% increase in serum creatinine within 48–72 hours post-contrast; pre-procedure isotonic saline hydration is the primary preventative measure, and metformin must be held for 48 hours post-procedure in high-risk patients.

Last updated: August 2026

  • 25.1 Classification of Contrast Agents: Osmolality, Viscosity & Iodine Concentration
  • Introduction to Radiopaque Contrast Media (ROCM)

In diagnostic radiography and fluoroscopy, soft tissue structures such as blood vessels, renal parenchyma, liver, and gastrointestinal mucosa often exhibit subject contrast that is too low to be distinguished from surrounding anatomic structures. Radiopaque Contrast Media (ROCM) are pharmacological compounds introduced into the body to alter the absorption coefficient of specific tissues, temporarily enhancing subject contrast and allowing visualization of physiological processes and lumen morphology.

The clinical selection of a contrast agent requires the radiologic technologist (RadTech) to balance diagnostic efficacy against potential patient toxicity, osmolality, chemical structure, and renal clearance dynamics.

Positive vs. Negative Contrast Agents

Contrast agents are broadly categorized into positive contrast agents and negative contrast agents based on their physical density, atomic number, and interaction with diagnostic X-ray beams. +-------------------------------------------------------------------------+

  • | CONTRAST AGENTS SPECTRUM |
  • +------------------------------------+------------------------------------+
  • | POSITIVE CONTRAST AGENTS | NEGATIVE CONTRAST AGENTS |
  • | - High Atomic Number (Z) | - Low Atomic Number (Z) |
  • | - High Physical Density | - Low Physical Density |
  • | - Absorbs X-rays (Photoelectric) | - Transmits X-rays Easily |
  • | - Radiopaque (White on Image) | - Radiolucent (Black on Image) |
  • | - Examples: Iodine (Z=53), | - Examples: Air (Z=7.6), CO2, |
  • | Barium (Z=56) | Oxygen |
  • +------------------------------------+------------------------------------+
  • 1. Positive Contrast Media (Radiopaque)

Mechanism : Positive contrast agents possess high atomic numbers ( Z Z Z ) and high physical mass density, which significantly increases the probability of photoelectric absorption of diagnostic X-ray photons compared to soft tissue ( Z eff ≈ 7.4 Z_{\text{eff}} \approx 7.4 Z eff ​ ≈ 7.4 ).

Primary Elements :

Iodine ( Z = 53 Z = 53 Z = 53 ) : Employed for intravascular (IV/IA), intrathecal, body cavity, and gastrointestinal administration. Iodine has a K-edge energy of 33.2 keV 33.2 \text{ keV} 33.2 keV , which aligns exceptionally well with the average photon energy of diagnostic X-ray beams ( 70 to 90 kVp 70 \text{ to } 90 \text{ kVp} 70 to 90 kVp ).

Barium ( Z = 56 Z = 56 Z = 56 ) : Employed exclusively in the form of Barium Sulfate ( BaSO 4 \text{BaSO}_4 BaSO 4 ​ ) insoluble suspension for oral and rectal gastrointestinal tract evaluation. Barium has a K-edge energy of 37.4 keV 37.4 \text{ keV} 37.4 keV . Because barium is insoluble and toxic if absorbed into the bloodstream, it must never be administered parenterally or in cases of suspected GI tract perforation.

Radiographic Appearance : Appears bright white (high radiopacity / density attenuation) on conventional radiograms and digital images.

2. Negative Contrast Media (Radiolucent)

Mechanism : Negative contrast agents consist of gases with low atomic numbers ( Z ≈ 7.6 Z \approx 7.6 Z ≈ 7.6 ) and low physical density. They attenuate significantly fewer X-ray photons than surrounding soft tissue, permitting maximum X-ray beam transmission.

Primary Agents : Room air, Carbon Dioxide ( CO 2 \text{CO}_2 CO 2 ​ ), and Oxygen. CO 2 \text{CO}_2 CO 2 ​ is rapidly absorbed by blood and expired through the lungs, making it an excellent intravascular negative contrast alternative for angiography in patients with severe iodinated contrast allergy or renal failure.

Radiographic Appearance : Appears dark or black (radiolucent) on radiographs.

Double-Contrast Techniques : Combining positive (barium or iodine) and negative (air or CO 2 \text{CO}_2 CO 2 ​ ) agents in mucosal studies (e.g., double-contrast barium enema, double-contrast upper GI series) coats mucosal linings with a thin layer of radiopaque barium while distending the organ lumen with radiolucent air, providing exquisite visualization of mucosal ulcerations and polyps.

Classification of Intravascular Iodinated Contrast Media

Intravascular contrast media are classified into three major generations based on their chemical molecular structure, ionic dissociation in solution, and resulting osmolality relative to human blood plasma ( ∼ 290 mOsm/kg H 2 O \sim 290 \text{ mOsm/kg H}_2\text{O} ∼ 290 mOsm/kg H 2 ​ O ).

1. High-Osmolar Contrast Media (HOCM) — Ionic Monomers

Chemical Structure : Formed by a benzene ring tri-iodinated with three iodine atoms at positions 2, 4, and 6, and a carboxyl group ( COO − \text{COO}^- COO − ) at position 1, paired with a soluble cation such as sodium ( Na + \text{Na}^+ Na + ) or meglumine.

Representative Agents : Diatrizoate (Hypaque, Renografin), Metrizoate , and Iothalamate .

Dissociation Dynamics : When dissolved in water or blood, each molecule dissociates into 2 active particles : 1 negatively charged anion (containing the 3 iodine atoms) and 1 positively charged cation ( Na + \text{Na}^+ Na + or meglumine). This yields a ratio of 3 iodine atoms to 2 particles (Ratio 1.5) .

Osmolality Range : 1500 to 2000 mOsm/kg H 2 O \text{H}_2\text{O} H 2 ​ O , which is approximately 5 to 8 times the osmolality of human blood plasma .

Clinical Toxicity : The extreme hyperosmolality causes massive fluid shifts from the intracellular and interstitial compartments into the intravascular space. This results in endothelial injury, vascular dilation, sensation of intense heat and pain during injection, hypervolemia, hyperosmolal strain on the myocardium, and a significantly higher incidence of adverse reactions. HOCM is largely obsolete for intravascular injection in modern radiologic practice.

2. Low-Osmolar Contrast Media (LOCM) — Non-Ionic Monomers & Ionic Dimers

Introduced to decrease the severe osmotic effects of HOCM while retaining diagnostic iodine opacity.

Non-Ionic Monomers :

Chemical Structure : Replaces the hydrophilic carboxyl group of the tri-iodinated benzene ring with non-ionizing hydrophilic hydroxyl/amide group attachments.

Representative Agents : Iohexol (Omnipaque), Iopamidol (Isovue), Ioversol (Optiray), and Iopromide (Ultravist).

Dissociation Dynamics : Does not dissociate in aqueous solution. Each dissolved molecule remains as 1 single particle containing 3 iodine atoms, yielding a ratio of 3 iodine atoms to 1 particle (Ratio 3.0) .

Osmolality Range : 600 to 800 mOsm/kg H 2 O \text{H}_2\text{O} H 2 ​ O , approximately 2 to 3 times the osmolality of blood plasma .

Ionic Dimers :

Representative Agent : Ioxaglate (Hexabrix). Combines two tri-iodinated benzene rings with a single carboxyl group, yielding 6 iodine atoms per 2 dissociated ions (Ratio 3.0) with an osmolality of ∼ 600 mOsm/kg H 2 O \sim 600 \text{ mOsm/kg H}_2\text{O} ∼ 600 mOsm/kg H 2 ​ O .

Clinical Safety : Non-ionic LOCM reduces vascular heat, pain, endovascular injury, and overall systemic adverse reaction rates by nearly 5-fold compared to HOCM.

3. Isosmolar Contrast Media (IOCM) — Non-Ionic Dimers

Chemical Structure : Formed by linking two non-ionic tri-iodinated benzene rings together without carboxyl groups.

Representative Agent : Iodixanol (Visipaque).

Dissociation Dynamics : Does not dissociate in solution. Each molecule contains 6 iodine atoms per 1 intact non-dissociating molecule (Ratio 6.0) .

Osmolality Range : 290 mOsm/kg H 2 O \text{H}_2\text{O} H 2 ​ O , which is isosmolar (equal) to human blood plasma .

Clinical Applications : Provides the highest safety profile for patients with severe pre-existing renal impairment, diabetes mellitus, cardiovascular instability, or high-risk intra-arterial interventional procedures.

Physical & Chemical Properties of Contrast Agents

The performance and physiological tolerance of iodinated contrast media are dictated by four fundamental physical and chemical parameters:

1. Osmolality

Osmolality measures the number of milliosmoles of active solute particles per kilogram of solvent ( mOsm/kg H 2 O \text{mOsm/kg H}_2\text{O} mOsm/kg H 2 ​ O ). Hyperosmolar fluids attract water across cell membranes via osmosis. When hyperosmolar contrast is injected into blood vessels, red blood cells creneate (shrink), vascular endothelial cells dehydrate, and circulating blood volume rapidly expands, causing transient vasodilation followed by systemic hypertension, fluid overload, and renal tubular damage.

2. Viscosity

Viscosity describes the fluid's internal friction and resistance to flow, measured in centipoise ( cP \text{cP} cP ).

Influencing Factors : Molecular weight, chemical structure (dimers are more viscous than monomers), and iodine concentration. Higher iodine concentrations possess higher viscosity.

Temperature Dependence : Viscosity is inversely proportional to temperature. Warming contrast media to body temperature ( 37 ∘ C 37^\circ\text{C} 3 7 ∘ C / 98.6 ∘ F 98.6^\circ\text{F} 98. 6 ∘ F ) using a calibrated contrast warming sleeve reduces viscosity by approximately 45% to 50% .

Clinical Significance : Warmed contrast flows smoothly through small-gauge IV catheters (e.g., 20G or 22G) and lowers injection pressure limits on automatic high-pressure injectors during high-flow angiographic runs.

3. Iodine Concentration

Expressed as milligrams of iodine per milliliter of solution ( mg I/mL \text{mg I/mL} mg I/mL , e.g., 300 mg I/mL 300 \text{ mg I/mL} 300 mg I/mL , 350 mg I/mL 350 \text{ mg I/mL} 350 mg I/mL , 370 mg I/mL 370 \text{ mg I/mL} 370 mg I/mL ). Higher iodine concentration yields greater X-ray attenuation and higher image contrast enhancement, but simultaneously increases osmolality, viscosity, and potential tissue toxicity.

4. Chemical Toxicity

Chemotoxicity relates to the chemical structure of the agent, including lipid solubility, binding capacity to blood proteins, and displacement of vital electrolytes such as calcium. Non-ionic formulations exhibit markedly lower chemotoxicity than ionic compounds.

Classification of Intravascular Contrast Agents

Contrast Media Category Chemical Class & Dissociation Ratio (Iodine : Particles) Osmolality Range ( mOsm/kg H 2 O \text{mOsm/kg H}_2\text{O} mOsm/kg H 2 ​ O ) Representative Examples Clinical Safety & Characteristics

High-Osmolar (HOCM) Ionic Monomers (Dissociates into 2 ions) 3:2 (1.5) 1500 – 2000 ( ∼ 5 × − 8 × \sim 5\times - 8\times ∼ 5 × − 8 × plasma) Diatrizoate (Hypaque), Metrizoate, Iothalamate High toxicity, severe heat/pain on injection; obsolete for IV injection.

Low-Osmolar (LOCM) Non-Ionic Monomers (Does not dissociate) 3:1 (3.0) 600 – 800 ( ∼ 2 × − 3 × \sim 2\times - 3\times ∼ 2 × − 3 × plasma) Iohexol (Omnipaque), Iopamidol (Isovue), Ioversol Standard of care for routine CT and fluoroscopy; low adverse reaction rate.

Low-Osmolar (LOCM) Ionic Dimers (Dissociates into 2 ions) 6:2 (3.0) ∼ 600 \sim 600 ∼ 600 ( ∼ 2 × \sim 2\times ∼ 2 × plasma) Ioxaglate (Hexabrix) Reduced osmolality ionic dimer; used in peripheral arteriography.

Isosmolar (IOCM) Non-Ionic Dimers (Does not dissociate) 6:1 (6.0) 290 (Isosmolar to blood plasma) Iodixanol (Visipaque) Equal to blood plasma osmolality; ideal for high-risk renal and cardiac patients.

  • Renal Safety & Contrast-Induced Nephropathy (CIN)
  • 1. Definition of Contrast-Induced Nephropathy (CIN)

Contrast-Induced Nephropathy (CIN) —also termed Contrast-Induced Acute Kidney Injury (CI-AKI)—is an acute decline in renal function occurring within 24 to 72 hours following intravascular administration of iodinated contrast media, after excluding other alternative etiologies. It is defined clinically by:

An absolute increase in serum creatinine of ≥ 0.5 mg/dL \ge 0.5 \text{ mg/dL} ≥ 0.5 mg/dL ( ≥ 44 μ mol/L \ge 44 \ \mu\text{mol/L} ≥ 44 μ mol/L ), OR

A relative percentage increase in serum creatinine of ≥ 25 % \ge 25\% ≥ 25% from baseline values.

2. Baseline Laboratory Metrics & Thresholds

Before administering IV or IA iodinated contrast, the technologist must verify recent baseline kidney function lab values:

Serum Creatinine (sCr) : Normal reference range is 0.6 to 1.2 mg/dL 0.6 \text{ to } 1.2 \text{ mg/dL} 0.6 to 1.2 mg/dL ( 53 to 106 μ mol/L 53 \text{ to } 106 \ \mu\text{mol/L} 53 to 106 μ mol/L ). Values above 1.5 mg/dL 1.5 \text{ mg/dL} 1.5 mg/dL indicate baseline renal insufficiency.

Estimated Glomerular Filtration Rate (eGFR) : The primary clinical index for renal clearance:

eGFR > 60 mL/min/1.73m 2 > 60 \text{ mL/min/1.73m}^2 > 60 mL/min/1.73m 2 : Normal kidney function; standard contrast administration carries negligible CIN risk.

eGFR 45 to 59 mL/min/1.73m 2 45 \text{ to } 59 \text{ mL/min/1.73m}^2 45 to 59 mL/min/1.73m 2 : Mildly decreased renal function; low CIN risk.

eGFR 30 to 44 mL/min/1.73m 2 30 \text{ to } 44 \text{ mL/min/1.73m}^2 30 to 44 mL/min/1.73m 2 : Moderate renal failure; increased CIN risk. Requires clinical evaluation, pre-procedure hydration, and minimization of contrast volume.

eGFR < 30 mL/min/1.73m 2 < 30 \text{ mL/min/1.73m}^2 < 30 mL/min/1.73m 2 : Severe renal failure / stage 4 chronic kidney disease. High risk of CIN; iodinated contrast is contraindicated unless diagnostic benefit strictly outweighs life-threatening risk.

3. Hydration Protocols for CIN Prevention

Intravenous volume expansion with isotonic 0.9 % 0.9\% 0.9% Normal Saline ( 1.0 to 1.5 mL/kg/hour 1.0 \text{ to } 1.5 \text{ mL/kg/hour} 1.0 to 1.5 mL/kg/hour ) initiated 6 to 12 hours prior to and continued 6 to 12 hours after contrast administration represents the single most effective, evidence-based strategy to prevent CIN. Hydration dilutes intravascular contrast, preserves renal blood flow, and accelerates renal excretion.

4. Metformin (Glucophage) Management Guidelines

Metformin is an oral biguanide antihyperglycemic agent prescribed for Type 2 diabetes mellitus. Metformin itself is not nephrotoxic . However, if contrast administration induces CIN, impaired renal excretion of metformin leads to drug accumulation and life-threatening metformin-associated lactic acidosis .

ACR Metformin Protocol :

For patients with eGFR > 60 mL/min/1.73m 2 > 60 \text{ mL/min/1.73m}^2 > 60 mL/min/1.73m 2 and no acute kidney injury, metformin does not need to be stopped prior to contrast and no follow-up renal function testing is required.

For patients with eGFR < 60 mL/min/1.73m 2 < 60 \text{ mL/min/1.73m}^2 < 60 mL/min/1.73m 2 , acute kidney injury, or undergoing intra-arterial contrast administration , metformin must be withheld at the time of or prior to the contrast procedure, and held for 48 hours post-procedure .

Metformin may only be restarted after 48 hours once follow-up laboratory testing confirms that renal function (sCr / eGFR) remains stable at baseline levels.